Home/Filings/4/0001415889-17-001079
4//SEC Filing

INNOVUS PHARMACEUTICALS, INC. 4

Accession 0001415889-17-001079

CIK 0001411879operating

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 6:00 AM ET

Size

5.7 KB

Accession

0001415889-17-001079

Insider Transaction Report

Form 4
Period: 2017-07-01
MIRZA ZIAD
Director
Transactions
  • Award

    Restricted Stock Units

    2017-07-01$0.11/sh+26,643$3,0001,649,263 total
    From: 2017-07-01Exp: 2027-07-01Common Stock (26,643 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
  • [F2]The Reporting Person was granted a Restricted Stock Unit on July 1, 2017 of 53,286 shares, which were fully vested on the date of the grant.
  • [F3]These restricted stock units were granted pursuant to the Issuer's 2016 Equity Incentive Plan.

Issuer

INNOVUS PHARMACEUTICALS, INC.

CIK 0001411879

Entity typeoperating
IncorporatedNV

Related Parties

1
  • filerCIK 0001411879

Filing Metadata

Form type
4
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 6:00 AM ET
Size
5.7 KB